The Program
What CMS Has Announced
The Medicare GLP-1 Bridge is now live. As of July 1, 2026, eligible Medicare Part D beneficiaries can access certain weight-loss medications for a flat $50 monthly copay through this CMS demonstration program, which runs through December 31, 2027.
That's genuinely good news for the millions of seniors who could benefit. The process is also becoming clearer: CMS has now confirmed which medications qualify, who processes the paperwork, and how the $50 copay works at the pharmacy counter. Here's what's confirmed as of mid-July.
What CMS Has Confirmed
- The Medicare GLP-1 Bridge launched July 1, 2026, and runs through December 31, 2027
- Three medications currently qualify: Wegovy (injection and tablet), Zepbound (KwikPen formulation only), and Foundayo
- CMS has contracted Humana as the single national processor handling prior authorization and pharmacy payment
- The $50 copay applies at the pharmacy counter and does not count toward your Part D deductible or your annual out-of-pocket cap
- Extra Help / Low-Income Subsidy cannot be used to reduce the $50 copay
- Your Part D plan does not need to opt in — the Bridge operates outside your regular plan
- Prior authorizations are being accepted even for beneficiaries who started GLP-1 therapy before July 1
- You are NOT eligible for the Bridge if you have type 2 diabetes, moderate-to-severe sleep apnea, or MASH (fatty liver disease) — even if you also meet the BMI/obesity criteria — because your Part D plan may already be able to cover a GLP-1 for that diagnosis
- You're also not eligible if you already filled a GLP-1 prescription through your Part D plan in 2026
The Challenge
Why This Is So Confusing
Normally, seniors look to their Medicare plan, their Annual Notice of Change, their formulary, or their insurance company for drug coverage information. This program is different.
The GLP-1 Bridge uses Humana as a central processor, working alongside your doctor and pharmacy. The mechanics are now documented — but that doesn't mean every doctor's office or pharmacy counter has caught up yet. Early reporting suggests the rollout is uneven: some practices are moving smoothly, others are still figuring out where the Bridge paperwork goes.
As an Independent Medicare Insurance Agent — and someone who takes Zepbound myself — I can tell you the mechanics make sense on paper now that CMS has published them. But paper and the pharmacy counter are two different things. If you're running into confusion, you're not alone, and it's worth being persistent.
Your Action Plan
What Seniors Should Do Now
If you are currently taking Zepbound, Wegovy, or another GLP-1 medication for weight management, don't wait until your next refill to check where things stand.
1
Call Your Pharmacy
Ask if they've set up Bridge billing with Humana and whether your prescription has moved through yet.
"The Medicare GLP-1 Bridge launched July 1 and uses Humana as the processor — has my prescription been submitted for prior authorization yet?"
2
Contact Your Prescribing Doctor
Confirm the prior authorization has actually been sent to Humana, not just to your regular Part D plan.
"Can you submit my prescription and prior authorization to Humana for the Medicare GLP-1 Bridge? I may qualify based on my BMI and health history."
3
Gather Your Medical Records
You may need: your starting weight and BMI, your diagnosis (obesity, or a qualifying condition such as heart failure, uncontrolled hypertension, chronic kidney disease, pre-diabetes, or a prior heart attack or stroke), the date you started GLP-1 therapy, and the exact medication and formulation.
4
Use the Free Doctor Discussion Guide
Download and bring our printable guide to your next appointment so your doctor knows exactly what program you are asking about.
Get the Free Guide →
Frequently Asked Questions
Common Questions About the GLP-1 Bridge
Do I need a new Medicare plan to get the $50 copay?
No. CMS has confirmed that Part D plans do not have to opt in for eligible beneficiaries to access the Bridge program. This operates outside the normal Part D coverage flow.
Which medications are covered under the Bridge?
Three medications currently qualify: Wegovy (injection and tablet), Zepbound (KwikPen formulation only — other Zepbound forms aren't included), and Foundayo. Confirm with your doctor which one matches your prescription.
Does my doctor need to do anything?
Yes. Your doctor sends your prescription to the pharmacy and submits a prior authorization request to Humana, the CMS-contracted processor. This can be done even if you started GLP-1 therapy before July 1 — those cases are reviewed retrospectively. Use our free Doctor Discussion Guide to help start that conversation.
Can my pharmacy process this automatically?
Not automatically. Your doctor has to submit the prior authorization to Humana first and get it approved before your pharmacy can apply the $50 copay. If your pharmacy hasn't processed a Bridge claim yet, that's normal this early — ask them to confirm they've set up Bridge billing with Humana.
I'm already taking Wegovy or Zepbound. Do I need to re-start or re-qualify?
If your only diagnosis is obesity or overweight-plus-comorbidity, no — CMS's eligibility is based on when you began GLP-1 therapy, even if that was before July 1, 2026. Your doctor documents your BMI and diagnosis from when you started treatment and submits that with your prior authorization. But if you also have type 2 diabetes, moderate-to-severe sleep apnea, or MASH, see the next question — you may not be eligible for the Bridge at all.
I have obesity, but I also have diabetes, sleep apnea, or fatty liver disease — can I use the Bridge?
No. CMS excludes you from the Bridge if you have type 2 diabetes, moderate-to-severe obstructive sleep apnea, or MASH (fatty liver disease) — even if you also meet the BMI-based obesity criteria. That's because those conditions are ones your regular Part D plan may already be able to cover a GLP-1 for. Ask your doctor to check whether your Part D plan covers your GLP-1 under one of those diagnoses instead of applying to the Bridge.
What if my plan or pharmacy hasn't heard of this program?
That's common in the first few weeks. The Bridge runs outside standard Part D communications, so some plans and pharmacies are still catching up. Your doctor's office and Humana are the two parties that actually need to know about it — not necessarily your Part D plan.
Does the $50 copay count toward my deductible or out-of-pocket limit?
No. The Bridge's $50 copay is separate from your Part D deductible and doesn't count toward your annual out-of-pocket cap. Extra Help / Low-Income Subsidy also can't be applied to reduce it.
Latest Updates
Update Center
This page is updated as CMS releases new information. Last updated July 15, 2026 — bookmark this page and check back before your next appointment.
Jul 15, 2026
Confirmed: three medications qualify. CMS has finalized the eligible drug list — Wegovy (all formulations), Zepbound (KwikPen only), and Foundayo. Humana is confirmed as the national processor for prior authorizations and pharmacy payments.
Jul 1, 2026
The Bridge officially launched. CMS confirmed the program went live nationwide as scheduled. Early reports suggest a mix of smooth approvals and pockets of confusion at pharmacies and provider offices still getting up to speed — if that's you, keep pushing and use our Doctor Discussion Guide.
June 2026
Doctor Discussion Guide published. Free printable guide now available at MedicareSelfEnroll.com/GLP1. Designed to help your doctor's office understand the Bridge program and begin your prior authorization.
June 2026
CMS confirms: prior authorizations will not be processed before July 1. Do not expect pharmacy access before the official start date.
Spring 2026
CMS announces Medicare GLP-1 Bridge Program. Eligible Part D beneficiaries may access certain GLP-1 medications for $50/month. Program operates outside standard Part D flow. Providers must submit prior authorization.
BV
Bill Vargas
Independent Medicare Insurance Agent · MedicareSelfEnroll.com
I help seniors understand what Medicare changes mean, what questions to ask, and what steps to take next. I take Zepbound myself, so I'm following the Bridge rollout both as a Medicare agent and as someone it may directly affect.